Inflammatory cytokines such as TNF, IL-6 and MCP-1 have been also shown to inhibit insulin action through modification of signaling properties of insulin receptor substrates, contributing to liver and skeletal muscle insulin resistance [25]–[27]. The gene discussed is IL6; the disease is Insulin resistance.